Full-Time

Manager Regulatory Affairs Promotional Compliance & Labeling Operations

Confirmed live in the last 24 hours

Acadia Pharmaceuticals

Acadia Pharmaceuticals

501-1,000 employees

Develops therapies for neurological disorders

Biotechnology
Healthcare

Compensation Overview

$110k - $138kAnnually

+ Bonus + Equity Awards

Senior

San Diego, CA, USA

Hybrid position requiring in-office presence.

Category
Risk & Compliance
Legal & Compliance

You match the following Acadia Pharmaceuticals's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Bachelor's degree in a scientific discipline or related field
  • Targeting 5 years of Regulatory Affairs experience
  • Strong understanding of FDA Regulatory Advertising and Promotion regulations
  • Strong understanding of FDA-OPDP 2253 submission process
  • Strong understanding of global regulatory labeling requirements
Responsibilities
  • Reviews all US, Canada, and EU promotional/non-promotional materials
  • Collaborate with Marketing, Marketing Operations, and Regulatory Operations
  • Ensures compliance with the FDA-OPDP 2253 submission process
  • Support MLR process optimization efforts
  • Support with formatting and QC of draft labeling text
  • Support implementation of labeling review and approval process
  • Maintain expertise regarding key labeling requirements worldwide
  • Support the development of annotated labels post approval
Acadia Pharmaceuticals

Acadia Pharmaceuticals

View

Acadia Pharmaceuticals develops therapies for neurological disorders, focusing on conditions like Parkinson's disease, schizophrenia, and Rett syndrome. The company conducts extensive research and clinical trials to create drugs that are safe and effective, seeking approval from regulatory bodies like the FDA before bringing them to market. Acadia differentiates itself by targeting unmet medical needs in neuroscience, ensuring that their products address significant challenges faced by patients. Their goal is to improve the quality of life for individuals with these disorders while also promoting diversity, equity, and inclusion within their operations.

Company Stage

Acquired

Total Funding

$813.4M

Headquarters

Dallas, Texas

Founded

1993

Simplify Jobs

Simplify's Take

What believers are saying

  • Acadia's recent Health Canada approval for Daybue boosts its market presence in Canada.
  • The exclusive license agreement with Saniona expands Acadia's drug portfolio with SAN711.
  • Hiring Thomas Andrew Garner as CCO strengthens Acadia's commercial leadership team.

What critics are saying

  • Increased competition in CNS drugs may impact Acadia's market share and growth.
  • Regulatory challenges could delay or prevent new drug approvals, affecting revenue.
  • High drug development costs may strain financial resources if trials are unsuccessful.

What makes Acadia Pharmaceuticals unique

  • Acadia focuses on unmet needs in neurological disorders like Parkinson's and Rett syndrome.
  • The company has a strong R&D pipeline with four product candidates in development.
  • Acadia collaborates with partners like Biovail to enhance drug development and commercialization.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

401(k) Company Match

Employee Stock Purchase Plan

Paid Vacation

Paid Holidays

Paid Sick Leave

Paid Parental Leave

Tuition Reimbursement